Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,613 | 51,175 | 41,826 | 13,700 | 46,678 |
| Marketable Securities | 390,323 | 125,283 | 87,201 | 479 | 8,860 |
| Receivables | 82,195 | 46,585 | 35,193 | 20,793 | 11,172 |
| Inventories | 63,721 | 49,073 | 19,896 | 26,993 | 21,195 |
| TOTAL | $637,235 | $276,141 | $187,885 | $64,156 | $92,092 |
| Non-Current Assets | |||||
| PPE Net | 50,022 | 32,923 | 17,151 | 19,631 | 18,409 |
| Intangibles | 0 | 0 | 0 | 1,457 | 1,784 |
| Other Non-Current Assets | 29,158 | 17,046 | 1,258 | 10,102 | 107 |
| TOTAL | $79,180 | $49,969 | $18,409 | $31,190 | $20,300 |
| Total Assets | $716,415 | $326,110 | $206,294 | $95,346 | $112,392 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,805 | 17,745 | 6,824 | 5,150 | 7,513 |
| Accrued Expenses | 4,783 | 8,014 | 3,930 | 2,832 | 1,629 |
| Other current liabilities | 31,602 | 35,128 | 26,904 | 11,089 | 6,943 |
| TOTAL | $103,852 | $99,396 | $66,288 | $36,085 | $31,476 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 76,541 | 78,960 |
| Deferred Revenues | 6,082 | 3,869 | 4,600 | 2,526 | 5,208 |
| Other Non-Current Liabilities | 246,258 | 31,735 | 8,731 | 7,181 | 5,274 |
| TOTAL | $246,258 | $31,735 | $8,731 | $88,409 | $86,843 |
| Total Liabilities | $350,110 | $131,131 | $75,019 | $124,494 | $118,319 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,505 | 59,726 | 57,718 | 44,699 | 3,134 |
| Common Shares | 62 | 59 | 57 | 10 | 3 |
| Retained earnings | -659,210 | -624,828 | -600,075 | -477,613 | -404,580 |
| Other shareholders' equity | 220 | 122 | -13 | 0 | -1 |
| TOTAL | $366,305 | $194,979 | $131,275 | $-29,148 | $-5,927 |
| Total Liabilities And Equity | $716,415 | $326,110 | $206,294 | $95,346 | $112,392 |